Cholinergic Stress Signals Accompany MicroRNA-Associated Stereotypic Behavior and Glutamatergic Neuromodulation in the Prefrontal Cortex.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
03 06 2020
Historique:
received: 05 05 2020
revised: 24 05 2020
accepted: 28 05 2020
entrez: 7 6 2020
pubmed: 7 6 2020
medline: 10 4 2021
Statut: epublish

Résumé

Stereotypic behavior (SB) is common in emotional stress-involved psychiatric disorders and is often attributed to glutamatergic impairments, but the underlying molecular mechanisms are unknown. Given the neuro-modulatory role of acetylcholine, we sought behavioral-transcriptomic links in SB using TgR transgenic mice with impaired cholinergic transmission due to over-expression of the stress-inducible soluble 'readthrough' acetylcholinesterase-R splice variant AChE-R. TgR mice showed impaired organization of behavior, performance errors in a serial maze test, escape-like locomotion, intensified reaction to pilocarpine and reduced rearing in unfamiliar situations. Small-RNA sequencing revealed 36 differentially expressed (DE) microRNAs in TgR mice hippocampi, 8 of which target more than 5 cholinergic transcripts. Moreover, compared to FVB/N mice, TgR prefrontal cortices displayed individually variable changes in over 400 DE mRNA transcripts, primarily acetylcholine and glutamate-related. Furthermore, TgR brains presented c-fos over-expression in motor behavior-regulating brain regions and immune-labeled AChE-R excess in the basal ganglia, limbic brain nuclei and the brain stem, indicating a link with the observed behavioral phenotypes. Our findings demonstrate association of stress-induced SB to previously unknown microRNA-mediated perturbations of cholinergic/glutamatergic networks and underscore new therapeutic strategies for correcting stereotypic behaviors.

Identifiants

pubmed: 32503154
pii: biom10060848
doi: 10.3390/biom10060848
pmc: PMC7355890
pii:
doi:

Substances chimiques

Cholinergic Agents 0
MicroRNAs 0
Glutamic Acid 3KX376GY7L

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : European Research Council
ID : 321501
Pays : International
Organisme : Israel Science Foundation
ID : 1016/18
Pays : International
Organisme : NOFAR Israel Innovations Authority
ID : 65812
Pays : International

Références

Elife. 2019 Nov 12;8:
pubmed: 31711569
Life Sci. 2004 Jan 2;74(7):803-14
pubmed: 14659969
Cell Rep. 2019 Oct 15;29(3):764-777.e5
pubmed: 31618642
Front Cell Neurosci. 2015 Dec 14;9:465
pubmed: 26696825
Neurobiol Dis. 2006 Apr;22(1):143-52
pubmed: 16326108
Neurodegener Dis. 2007;4(2-3):171-84
pubmed: 17596712
Eur Rev Med Pharmacol Sci. 2017 Mar;21(5):1080-1087
pubmed: 28338184
Eur J Neurosci. 2007 Jan;25(1):87-98
pubmed: 17241270
C R Acad Sci III. 1998 Feb-Mar;321(2-3):91-6
pubmed: 9759326
Cereb Cortex. 2005 Apr;15(4):419-30
pubmed: 15749986
J Cell Biochem. 2018 May;119(5):3783-3797
pubmed: 29236313
Mol Psychiatry. 2018 Jul 9;:
pubmed: 29988084
J Neurosci. 2003 May 1;23(9):3855-68
pubmed: 12736356
Mol Psychiatry. 2002;7(8):874-85
pubmed: 12232781
Neurobiol Learn Mem. 2016 Oct;134 Pt A:145-161
pubmed: 26642918
Brain Res Brain Res Rev. 2000 Aug;33(1):1-12
pubmed: 10967351
Schizophr Res. 2001 Mar 1;47(2-3):107-16
pubmed: 11278127
Arch Gen Psychiatry. 2000 Aug;57(8):741-8
pubmed: 10920461
Arch Gen Psychiatry. 1998 Apr;55(4):326-33
pubmed: 9554428
Bioinformatics. 2004 Jun 12;20(9):1464-5
pubmed: 14962934
PLoS Genet. 2014 Sep 04;10(9):e1004580
pubmed: 25188300
Neurosci Lett. 1990 Jan 1;108(1-2):58-64
pubmed: 2304638
Brain Res Brain Res Rev. 1997 Apr;23(3):237-56
pubmed: 9164673
J Neurosci. 2013 Aug 28;33(35):14017-30
pubmed: 23986238
Mov Disord. 1997 Jan;12(1):47-52
pubmed: 8990053
Science. 2000 Jul 28;289(5479):633-7
pubmed: 10915629
Brain Struct Funct. 2013 Jan;218(1):59-72
pubmed: 22246100
Sci Am. 1994 Jun;270(6):50-7
pubmed: 8023118
Mol Ther Nucleic Acids. 2019 Dec 6;18:567-579
pubmed: 31678733
Genome Biol. 2014;15(12):550
pubmed: 25516281
Neuropsychopharmacology. 2002 Jul;27(1):92-104
pubmed: 12062910
Trends Neurosci. 2006 Apr;29(4):216-24
pubmed: 16516310
Neuroscientist. 2004 Apr;10(2):118-28
pubmed: 15070486
Science. 2001 Nov 2;294(5544):1117-22
pubmed: 11691998
Trends Neurosci. 2009 Apr;32(4):199-206
pubmed: 19268374
Brain Res. 2000 Sep 15;877(1):23-30
pubmed: 10980239
Physiol Behav. 1996 Jun;59(6):1163-70
pubmed: 8737907
Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11851-6
pubmed: 15280545
Lab Anim Sci. 1991 Aug;41(4):323-8
pubmed: 1658478
Am J Med Genet. 1995 Nov 20;59(3):283-90
pubmed: 8599350
Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3573-8
pubmed: 23401542
J Neurosci. 2004 Oct 13;24(41):8950-60
pubmed: 15483114
Behav Brain Res. 2002 Oct 17;136(1):83-92
pubmed: 12385793
Nat Neurosci. 2000 Apr;3(4):377-83
pubmed: 10725928
Biol Psychiatry. 2001 Apr 15;49(8):655-64
pubmed: 11313033
Brain Res Brain Res Rev. 2005 Feb;48(1):98-111
pubmed: 15708630
Ann N Y Acad Sci. 2003 Apr;986:395-400
pubmed: 12763856
PLoS One. 2018 Oct 18;13(10):e0206239
pubmed: 30335862
Cell. 2018 Mar 22;173(1):20-51
pubmed: 29570994
Ann N Y Acad Sci. 2001 May;935:107-17
pubmed: 11411161
Behav Neurosci. 1996 Oct;110(5):998-1005
pubmed: 8919002
Dev Biol. 2012 Feb 15;362(2):162-71
pubmed: 22094018
Neurosci Biobehav Rev. 2001 Dec;25(7-8):669-78
pubmed: 11801292
Cell Death Dis. 2019 Apr 8;10(4):316
pubmed: 30962417
J Neurosci. 2000 Mar 15;20(6):2369-82
pubmed: 10704511
Learn Mem. 2008 Dec 02;15(12):899-908
pubmed: 19050162
Sci Rep. 2015 Feb 06;5:8296
pubmed: 25656819
Biol Psychiatry. 1996 May 1;39(9):776-83
pubmed: 8731518
Synapse. 1994 Feb;16(2):123-36
pubmed: 7910986
Am J Med Genet B Neuropsychiatr Genet. 2007 Jun 5;144B(4):484-91
pubmed: 17427195
Front Syst Neurosci. 2016 Mar 01;10:17
pubmed: 26973474
Front Mol Neurosci. 2014 Feb 10;7:9
pubmed: 24574962
BMC Bioinformatics. 2009 Oct 12;10:328
pubmed: 19821977
Nat Rev Genet. 2008 Feb;9(2):102-14
pubmed: 18197166
Curr Opin Neurol. 2004 Apr;17(2):107-13
pubmed: 15021235
Nat Rev Neurosci. 2011 Nov 30;13(1):22-37
pubmed: 22127301
Science. 2000 Dec 22;290(5500):2315-9
pubmed: 11125148
Curr Biol. 2017 Aug 7;27(15):2307-2317.e5
pubmed: 28736170
Nat Rev Neurosci. 2001 Apr;2(4):294-302
pubmed: 11283752
Sci STKE. 2002 Oct 29;2002(156):re14
pubmed: 12407224
Anxiety. 1996;2(2):90-4
pubmed: 9160607
Cell Rep. 2018 Aug 28;24(9):2231-2247.e7
pubmed: 30157420
Biol Psychiatry. 2006 Oct 1;60(7):741-51
pubmed: 16904653
Trends Neurosci. 2000 Oct;23(10 Suppl):S71-7
pubmed: 11052223
Int J Mol Sci. 2019 Jun 16;20(12):
pubmed: 31208140
Proc Natl Acad Sci U S A. 2010 May 4;107(18):8452-6
pubmed: 20404184
Brain Res. 1997 Feb 28;749(2):344-6
pubmed: 9138736
Biol Psychiatry. 1987 Aug;22(8):995-1003
pubmed: 3607140
Science. 2019 Dec 20;366(6472):
pubmed: 31806698
J Clin Psychiatry. 2004 Mar;65(3):426-31
pubmed: 15096084
Neuroscience. 1998 May;84(1):193-200
pubmed: 9522373
FASEB J. 2019 Jun;33(6):7213-7224
pubmed: 30865837
Brain Res Brain Res Rev. 2004 Jul;45(3):196-212
pubmed: 15210304
Nature. 1998 May 28;393(6683):373-7
pubmed: 9620801
Science. 2002 Jan 18;295(5554):508-12
pubmed: 11799248
Brain Dev. 2003 Dec;25 Suppl 1:S15-9
pubmed: 14980366
J Comp Neurol. 1990 Jun 22;296(4):517-30
pubmed: 2113539
Trends Neurosci. 2015 Jul;38(7):448-58
pubmed: 26100140
Br J Psychiatry. 1995 Aug;167(2):249-54
pubmed: 7582678
Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5512-7
pubmed: 15060281
Mol Psychiatry. 2004 Feb;9(2):174-83
pubmed: 14581933
Mov Disord. 2003 Nov;18(11):1392-5
pubmed: 14639691
J Neuropsychiatry Clin Neurosci. 2011 Spring;23(2):121-5
pubmed: 21677237
J Child Psychol Psychiatry. 1999 Sep;40(6):839-49
pubmed: 10509879
Pharmacopsychiatry. 1999 Jan;32(1):13-20
pubmed: 10071178
Physiology (Bethesda). 2012 Jun;27(3):167-77
pubmed: 22689792
Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):283-8
pubmed: 12509514
Brain Res. 2002 Sep 13;949(1-2):60-70
pubmed: 12213300
J Neurosci. 2009 Feb 4;29(5):1381-94
pubmed: 19193885

Auteurs

Gilli Moshitzky (G)

The Institute of Life Sciences and The Edmond and Lily Safra Center of Brain Science, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.

Shai Shoham (S)

Herzog Medical Center, Givat Shaul, P.O. Box 3900, Jerusalem 9103702, Israel.

Nimrod Madrer (N)

The Institute of Life Sciences and The Edmond and Lily Safra Center of Brain Science, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.

Amir Mouhammed Husain (AM)

The Institute of Life Sciences and The Edmond and Lily Safra Center of Brain Science, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.

David S Greenberg (DS)

The Institute of Life Sciences and The Edmond and Lily Safra Center of Brain Science, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.

Raz Yirmiya (R)

Department of Psychology, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.

Yoram Ben-Shaul (Y)

Department of Medical Neurobiology, The Institute of Medical Research Israel-Canada, Jerusalem 9112102, Israel.

Hermona Soreq (H)

The Institute of Life Sciences and The Edmond and Lily Safra Center of Brain Science, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH